James Daniel Kish - 31 Oct 2021 Form 3 Insider Report for Sunshine Biopharma, Inc (SBFM)

Role
Director
Signature
James Daniel Kish
Issuer symbol
SBFM
Transactions as of
31 Oct 2021
Net transactions value
$0
Form type
3
Filing time
14 Dec 2021, 12:20:42 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SBFM Common Stock 287,100 31 Oct 2021 Direct
holding SBFM Common Stock 2,500 31 Oct 2021 Held in the name of Reporting Person's Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.